fda tirzepatide shortage update says the weight-loss drug is over RECAP: Recent Updates in the

mentorship for a junior investigator at the University of NebraskaLincoln who received an NIH-supported training grant

Dehydration represents another consideration, as GLP-1 receptor agonists can reduce fluid intake through appetite suppression, and gastrointestinal side effects like vomiting or diarrhea may exacerbate fluid losses

Each new generation of weight loss medications appears more effective than the last

The graduate student and statehouse intern is working on a bill that would restore the full GLP-1 coverage for her and others

Reports show that users often deal with: Nausea and vomiting Fatigue Constipation or diarrhea Bloating and abdominal pain Headaches Muscle loss Over time, these side effects can disrupt quality of life, digestion, and overall energy levels